Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemorrhagic Fevers, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06648603
What this trial is testing

Citizen Action for Sustainable Dengue Control in Sub-Saharan Africa

Who this might be right for
Dengue
Swiss Tropical & Public Health Institute 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05011123
What this trial is testing

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Who this might be right for
Yellow Fever
Sanofi Pasteur, a Sanofi Company 690
Not applicableStudy completedNCT02658331
What this trial is testing

Evaluation of the FilmArray BioThreat-E Test

Who this might be right for
Ebola Virus Disease
BioMérieux 156
Testing effectiveness (Phase 2)Ended earlyNCT05201794
What this trial is testing

JNJ-64281802 for the Prevention of Dengue Infection

Who this might be right for
Dengue
Janssen Research & Development, LLC 1,595
Testing effectiveness (Phase 2)Study completedNCT05284097
What this trial is testing

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Who this might be right for
Virus DiseasesHemorrhagic Fever, EbolaInfections+8 more
London School of Hygiene and Tropical Medicine 133
Testing effectiveness (Phase 2)Study completedNCT02598388
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 578
Early research (Phase 1)Study completedNCT02368119
What this trial is testing

Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 60
Early research (Phase 1)Ended earlyNCT02451891
What this trial is testing

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Who this might be right for
Ebola Virus Disease
University of Oxford 38
Not applicableEnded earlyNCT03889106
What this trial is testing

Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Patients With Lassa Fever

Who this might be right for
Lassa Fever
University of Oxford 2
Large-scale testing (Phase 3)Study completedNCT03341637
What this trial is testing

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)

Who this might be right for
Dengue
Takeda 400
Early research (Phase 1)Study completedNCT01110551
What this trial is testing

Tetravalent Chimeric Dengue Vaccine Trial

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 72
Large-scale testing (Phase 3)UnknownNCT00966628
What this trial is testing

Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)

Who this might be right for
Dengue Shock Syndrome
Innogene Kalbiotech Pte. Ltd 50
Not applicableStudy completedNCT03206541
What this trial is testing

Neurologic Manifestations of the Arbovirus Infection in Colombia

Who this might be right for
EncephalitisMyelitisGuillain-Barre Syndrome+5 more
Johns Hopkins University 570
Early research (Phase 1)Study completedNCT02408913
What this trial is testing

VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 140
Not applicableActive Not RecruitingNCT07158190
What this trial is testing

Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda).

Who this might be right for
Dengue
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Not applicableStudy completedNCT05505682
What this trial is testing

Impact of Project Wolbachia - Singapore on Dengue Incidence

Who this might be right for
Dengue
National Environment Agency, Singapore 724,428
Not applicableStudy completedNCT07591740
What this trial is testing

Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users

Who this might be right for
Hemorrhagic Fever
Cepheid 725
Not applicableAvailableNCT03576690
What this trial is testing

R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Regeneron Pharmaceuticals
Early research (Phase 1)Study completedNCT00919178
What this trial is testing

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

Who this might be right for
Dengue Shock SyndromeDengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 70
Early research (Phase 1)Study completedNCT04093076
What this trial is testing

Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana

Who this might be right for
Lassa Fever
Inovio Pharmaceuticals 220
Next Page